Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05189262 · ClinicalTrials.gov registry record
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
A clinical trial of Cardiac Surgery and Cardiopulmonary Bypass, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT05189262: Recruiting study of Cardiac Surgery and Cardiopulmonary Bypass, sponsored by University of Maryland, Baltimore.
NCT05189262 is a study of Cardiac Surgery and Cardiopulmonary Bypass that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 150 participants, below the 738-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05189262, a study of Cardiac Surgery and Cardiopulmonary Bypass, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Studying the dynamics of red blood cell lysis, pfH, protective proteins and organ injury, limits will be set for safe levels of pfH following the use of CPB. These results will be compared to existing laboratory-based methods for determining red blood cell damage to predict CPB assist device safety. Further, results from the studies described in this proposal will help develop therapeutic strategies to benefit patients by early detection of pfH and clearance protein levels that occur during CPB.
Primary Outcome
Change in Measure hemoglobin released into plasma (pfH), lactate dehydrogenase and iron
Conditions Studied
Interventions
- OTHER Blood and urine collection
Study Locations (1)
Maryland
- Center for Blood Oxygen Transport and Hemostasis - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-03-22 |
| Est. Completion | 2027-12-01 |
What NCT05189262 shows while recruiting
NCT05189262 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 738-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (80% lower).
The record links to 3 conditions, with Cardiac Surgery appearing as the primary indexed condition, and to 1 intervention - of which Blood and urine collection is the first listed.
NCT05189262 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05189262 about?
NCT05189262 is a clinical study titled "Cardiopulmonary Bypass Induced Red Blood Cell Lysis". Studying the dynamics of red blood cell lysis, pfH, protective proteins and organ injury, limits will be set for safe levels of pfH following the use of CPB. These results will be compared to existing laboratory-based methods for determining red blood cell damage to predict CPB assist device safety....
What is the current status of trial NCT05189262?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2022-03-22. Estimated completion is 2027-12-01.
What conditions does trial NCT05189262 study?
This clinical trial studies the following conditions: Cardiac Surgery, Cardiopulmonary Bypass, Kidney Injury, Acute.
What interventions are being tested in trial NCT05189262?
The interventions under investigation include: Blood and urine collection (OTHER).
Who is sponsoring clinical trial NCT05189262?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05189262 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05189262's enrollment target sits among peer trials
150 9th of 19 higher than 10 of 19 other Cardiac Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
RECRUITING · NA
-
Oral Methadone in Cardiac Surgery
RECRUITING · Phase 4
-
Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery
RECRUITING · Early Phase 1
-
Assessing the Burden of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
RECRUITING
-
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
RECRUITING · Phase 3
-
ESP/PIF for Sternotomy
ACTIVE NOT RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI